REQUEST A DEMO
Total
USD $0.00
Search more companies

Ultra Chiron Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ultra Chiron Pharmaceuticals Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ultra Chiron Pharmaceuticals Pvt Ltd is a company based in India, with its head office in Chandigarh. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on July 20, 1993. In 2025, the company reported a net sales revenue drop of 25.89%. Its’ total assets recorded a growth of 30.73%. In, 2025, the company’s net profit margin increased by 0.61%.

Legal Address
Plot No 80 Industrial Area Phase Ii
Chandigarh; Punjab; Postal Code: 160001

Contact Details: Purchase the Ultra Chiron Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Registered Capital:
Purchase the Ultra Chiron Pharmaceuticals Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Ultra Chiron Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
July 20, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Company Performance
Financial values in the chart are available after Ultra Chiron Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-25.89%
Total Operating Revenue
-25.4%
Operating Profit
-35.76%
EBITDA
-13.1%
Net Profit/Loss for the Period
40.4%
Total Assets
30.73%
Total Equity
5.71%
Operating Profit Margin
-0.18%
Net Profit Margin
0.61%
Return on Equity (ROE)
1.33%
Quick Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?